MEIP logo

MEI Pharma (MEIP) Stock

Profile

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

18 December 2003

Indexes:

Not included

Website:

http://meipharma.com

Description:

MEI Pharma is a biotechnology company focused on developing innovative therapies for cancer treatment. They work on creating new drugs that target specific cancer cells, aiming to improve patient outcomes and quality of life. Their research includes both clinical trials and partnerships with other organizations in the healthcare field.

Key Details

Price

$2.81

Market Cap

$18.72 M(Small cap)

Last Dividend

$1.75

TTM Dividend Yield

-

Annual Revenue

$65.30 M(+33.76% YoY)

Annual EPS

$2.67(+155.86% YoY)

PE Ratio

-

Annual ROE

61.68%

Annual Debt To Equity

0.00

Beta

0.59

Events Calendar

Earnings

Next earnings date:

Feb 13, 2025

Recent quarterly earnings:

Nov 12, 2024

Recent annual earnings:

Sept 19, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

Nov 16, 2023
Splits

Next split:

N/A

Recent split:

Apr 17, 2023

Analyst ratings

Recent major analysts updates

23 July '24 Laidlaw & Co.
Hold
12 Apr '24 Stifel
Hold
14 Feb '24 Stifel
Hold
27 Sept '23 Stifel
Hold
23 May '23 Brookline Capital
Buy
12 May '23 Stifel
Hold
13 Feb '23 HC Wainwright & Co.
Buy
08 Feb '23 Jefferies
Underperform
06 Dec '22 Truist Securities
Hold
06 Dec '22 BTIG
Neutral

Screeners with MEIP included

Small cap stocks
NASDAQ earnings calendar
Stocks below SMA 200
Stocks with all time high dividends
Stocks recommended to hold

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$2.81
MEIP price is $2.81

Price YTD Change

-52.37%
MEIP price is down -52.37% since January 1st

Price All-time High

$15324.00
MEIP price is currently -99.98% below its historical high of $15324.00

Market Cap

$18.72 M
MEIP market capitalization is $18.72 million

Beta

0.59
MEIP beta is 0.59

200-day SMA

$3.21
MEIP 200-day simple moving average is currently -12.55% below its 200-day simple moving average

14-day RSI

43.20
MEIP 14-day relative strength index is 43.20

Dividend

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Last Paid Dividend

$1.75
MEIP dividend per share is $1.75

Annual Dividend Per Share

$1.75
MEIP annual dividend per share is $1.75

Annual Dividend Sector Rank

67.5%
MEIP annual dividend per share is higher than 67.5% of companies in Healthcare sector

Annual Payout Ratio

65.59%
MEIP annual payout ratio is 65.59%

Annual Dividends Paid

$11.66 M
MEIP annual dividends paid is $11.66 million

Annual FCF

-$50.48 M
MEIP annual free cash flow is -$50.48 million

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Annual Revenue 3-Year Change

+87.66%
MEIP annual revenue is up +87.66% over the past 3 years

Annual Net Income 3-Year Change

+143.03%
MEIP annual net profit is up +143.03% over the past 3 years

Annual EPS 3-Year Change

+122.25%
MEIP annual earnings per share is up +122.25% over the past 3 years

Annual EPS Estimate

-$4.62
MEIP annual earnings per share is currently -157.79% lower than the consensus analysts' forecast

Annual Operating Profit

$25.44 M
MEIP annual operaing income is $25.44 million

Annual Operating Profit 3-Year Change

+142.1%
MEIP annual operaing income is up +142.1% over the past 3 years

Efficiency

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Annual Operating Margin Sector Rank

98.84%
MEIP annual operating profit margin is higher than 98.84% of companies in Healthcare sector

Annual Net Margin Sector Rank

97.41%
MEIP annual net profit margin is higher than 97.41% of companies in Healthcare sector

Annual ROE

61.68%
MEIP annual return on equity is 61.68%

Annual ROA

21.92%
MEIP annual return on assets is 21.92%

Annual EBIT

$25.44 M
MEIP annual earnings before interest & taxes is $25.44 million

Annual EBITDA

$25.82 M
MEIP annual earnings before interest, taxes, depreciation & amortization is $25.82 million

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PB Ratio Sector Rank

31.64%
MEIP price to book ratio is higher than 31.64% of companies in Healthcare sector

Enterprise Value

$11.77 M
MEIP enterprise value is $11.77 million

Enterprise Value 1-Year Change

-76.26%
MEIP enterprise value is down -76.26% year-on-year

EV/EBITDA

-0.31
MEIP EV/EBITDA is -0.31

EV/EBITDA Sector Rank

62.01%
MEIP EV/EBITDA is higher than 62.01% of companies in Healthcare sector

Liquidity

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Annual Debt To Equity Sector Rank

47.83%
MEIP annual debt to equity ratio is higher than 47.83% of companies in Healthcare sector

Annual Current Ratio

4.88
MEIP annual current ratio is 4.88

Annual Current Ratio Sector Rank

65.25%
MEIP annual current ratio is higher than 65.25% of companies in Healthcare sector

Annual Total Assets

$41.38 M
MEIP annual total assets is $41.38 million

Annual Current Assets

$40.77 M
MEIP annual total current assets is $40.77 million

Annual Total Liabilities

$8.36 M
MEIP annual total liabilities is $8.36 million

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Annual CFO 3-Year Change

-57.91%
MEIP annual cash flow from operations is down -57.91% over the past 3 years

Annual CFI 3-Year Change

+98.88%
MEIP annual cash flow from investing activities is up +98.88% over the past 3 years

Annual CFF 3-Year Change

-442.21%
MEIP annual cash flow from financing activities is down -442.21% over the past 3 years

Annual CAPEX

$7000.00
MEIP annual capital expenditures is $7000.00

Annual CAPEX 3-Year Change

-99.01%
MEIP annual capital expenditures is down -99.01% over the past 3 years

Annual FCF

-$50.48 M
MEIP annual free cash flow is -$50.48 million

Annual FCF 3-Year Change

-54.51%
MEIP annual free cash flow is down -54.51% over the past 3 years

Institutional Ownership

Similar stocks

CPIX logo
Cumberland Pharmaceuticals (CPIX)
Gelteq Limited Ordinary Shares (GELS)
LFWD logo
ReWalk Robotics (LFWD)
NMTC logo
NeuroOne Medical Technologies (NMTC)
RVP logo
Retractable Technologies (RVP)
CYTH logo
Cyclo Therapeutics (CYTH)
BIAF logo
bioAffinity Technologies (BIAF)
BFRG logo
Bullfrog AI Holdings Common Stock (BFRG)
COSM logo
Cosmos Holdings (COSM)
MEI Pharma, Inc. (MEIP) Reports Q2 Loss, Misses Revenue Estimates
MEI Pharma, Inc. (MEIP) Reports Q2 Loss, Misses Revenue Estimates
MEI Pharma, Inc. (MEIP) Reports Q2 Loss, Misses Revenue Estimates
MEIP
Zacks Investment Research13 February 2024

MEI Pharma, Inc. (MEIP) came out with a quarterly loss of $1.66 per share versus the Zacks Consensus Estimate of a loss of $1.46. This compares to earnings of $1.60 per share a year ago.

All You Need to Know About MEI Pharma, Inc. (MEIP) Rating Upgrade to Strong Buy
All You Need to Know About MEI Pharma, Inc. (MEIP) Rating Upgrade to Strong Buy
All You Need to Know About MEI Pharma, Inc. (MEIP) Rating Upgrade to Strong Buy
MEIP
Zacks Investment Research29 September 2023

MEI Pharma, Inc. (MEIP) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

MEI Pharma, Inc. (MEIP) Q4 2023 Earnings Call Transcript
MEI Pharma, Inc. (MEIP) Q4 2023 Earnings Call Transcript
MEI Pharma, Inc. (MEIP) Q4 2023 Earnings Call Transcript
MEIP
Seeking Alpha26 September 2023

MEI Pharma, Inc. (NASDAQ:MEIP ) Q4 2023 Earnings Call Transcript September 26, 2023 5:00 PM ET Company Participants David Walsey - SVP, Corporate Affairs David Urso - President & CEO Jay File - CFO Richard Ghalie - CMO Conference Call Participants Yale Jen - Laidlaw & Company Stephen Willey - Stifel Operator Good day and welcome to the MEI Fiscal Year-End Earnings Call. My name is Gary and I will be the conference facilitator today.

MEI Pharma, Inc. (MEIP) Reports Q3 Loss, Tops Revenue Estimates
MEI Pharma, Inc. (MEIP) Reports Q3 Loss, Tops Revenue Estimates
MEI Pharma, Inc. (MEIP) Reports Q3 Loss, Tops Revenue Estimates
MEIP
Zacks Investment Research11 May 2023

MEI Pharma, Inc. (MEIP) came out with a quarterly loss of $2.32 per share versus the Zacks Consensus Estimate of a loss of $2.60. This compares to loss of $3.40 per share a year ago.

FAQ

  • What is the primary business of MEI Pharma?
  • What is the ticker symbol for MEI Pharma?
  • Does MEI Pharma pay dividends?
  • What sector is MEI Pharma in?
  • What industry is MEI Pharma in?
  • What country is MEI Pharma based in?
  • When did MEI Pharma go public?
  • Is MEI Pharma in the S&P 500?
  • Is MEI Pharma in the NASDAQ 100?
  • Is MEI Pharma in the Dow Jones?
  • When was MEI Pharma's last earnings report?
  • When does MEI Pharma report earnings?
  • Should I buy MEI Pharma stock now?

What is the primary business of MEI Pharma?

MEI Pharma is a biotechnology company focused on developing innovative therapies for cancer treatment. They work on creating new drugs that target specific cancer cells, aiming to improve patient outcomes and quality of life. Their research includes both clinical trials and partnerships with other organizations in the healthcare field.

What is the ticker symbol for MEI Pharma?

The ticker symbol for MEI Pharma is NASDAQ:MEIP

Does MEI Pharma pay dividends?

No, MEI Pharma does not pay dividends

What sector is MEI Pharma in?

MEI Pharma is in the Healthcare sector

What industry is MEI Pharma in?

MEI Pharma is in the Biotechnology industry

What country is MEI Pharma based in?

MEI Pharma is headquartered in United States

When did MEI Pharma go public?

MEI Pharma's initial public offering (IPO) was on 18 December 2003

Is MEI Pharma in the S&P 500?

No, MEI Pharma is not included in the S&P 500 index

Is MEI Pharma in the NASDAQ 100?

No, MEI Pharma is not included in the NASDAQ 100 index

Is MEI Pharma in the Dow Jones?

No, MEI Pharma is not included in the Dow Jones index

When was MEI Pharma's last earnings report?

MEI Pharma's most recent earnings report was on 12 November 2024

When does MEI Pharma report earnings?

The next expected earnings date for MEI Pharma is 13 February 2025

Should I buy MEI Pharma stock now?

As of today, analysts generally recommend a 'Hold' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions